# Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome

> **NCT03355469** · PHASE2,PHASE3 · COMPLETED · sponsor: **Rutgers University** · enrollment: 91 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo
- **BEHAVIORAL:** Low Intensity Exercise
- **BEHAVIORAL:** High Intensity Exercise

## Key facts

- **NCT ID:** NCT03355469
- **Lead sponsor:** Rutgers University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-07
- **Primary completion:** 2024-03-11
- **Final completion:** 2024-05-23
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03355469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03355469, "Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03355469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*